Skip to main content
SpringerLink
Log in

Barrett’s Esophagus: Am I Going to Get Cancer? What Should I Do to Avoid It?

  • Chapter
  • First Online:
Book cover Gastrointestinal Motility Disorders

  • 1269 Accesses

Abstract

Barrett’s esophagus has been a controversial issue for over half a century in that the risk of esophageal adenocarcinoma associated with this condition warrants early detection of this disease, but there are disagreements regarding how best to do this. This chapter reviews the pathogenesis, histologic variations, epidemiology, surveillance tools, and treatment modalities as they pertain to Barrett’s esophagus. The general consensus, per major gastroenterological societies, is to screen and survey those at significant risk with endoscopy. Though the molecular pathogenesis has been extensively studied, precise risk stratification using biomarkers has not yet been delineated. Treatment modalities have and continue to evolve during this time, allowing for more endoscopic eradication options. However, this is a dynamic topic, and there is much more to be learnt about the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Feldman M, Friedman LS, Brandt LJ. Sleisinger and Fordtran’s gastrointestinal and liver disease. 10th ed. Philadelphia: Saunders; 2016.

    Google Scholar 

  2. Spechler S, et al. American Gastroenterological Association medical position statement on the Management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–91.

    Article  PubMed  Google Scholar 

  3. Hvid-Jensen F, Pedersen L, Drewes AM, et al. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med. 2011;365:1375–83.

    Article  CAS  PubMed  Google Scholar 

  4. Dulae GS, et al. Preoperative prevalence of Barrett’s esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology. 2002;122:26–33.

    Article  Google Scholar 

  5. Fleischer DE, Overhold BF, Sharma VK, et al. Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc. 2008;68:867–76.

    Article  PubMed  Google Scholar 

  6. Spechler SJ, Fitzgerald RC, Prasad GA, et al. History, molecular mechanisms, and endoscopic treatment of Barrett’s esophagus. Gastroenterology. 2010;138:854–69.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Shaheen N, et al. ACG clinical guideline: diagnosis and Management of Barrett’s esophagus. Am J Gastroenterol. 2016;111(1):30–50.

    Article  CAS  PubMed  Google Scholar 

  8. Souza RF, Krishnan K, Spechler SJ. Acid, bile and CDX: the ABC’s of making Barrett’s metaplasia. Am J Physiol Gastrointest Liver Physiol. 2008;295:G211–8.

    Article  CAS  PubMed  Google Scholar 

  9. Avissar NE, Toia L, Hu Y, et al. Bile acid alone, or in combination with acid, induces CDX2 expression through activation of the epidermal growth factor receptor (EGFR). J Gastrointest Surg. 2009;13:212–22.

    Article  PubMed  Google Scholar 

  10. Milano F, van Baal JW, Buttar NS, et al. Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells. Gastroenterology. 2007;132:2412–21.

    Article  CAS  PubMed  Google Scholar 

  11. Curvers W, et al. Low-grade dysplasia in Barrett’s esophagus: overdiagnosed and underestimated. Am J Gastro. 2010;105:1523–30.

    Article  Google Scholar 

  12. Pandolfino JE, El-Serag HB, Zhang Q, et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006;130:639–49.

    Article  PubMed  Google Scholar 

  13. Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett’s esophagus: a systematic review and meta-analysis. Am J Epidemiol. 2008;168:237–49.

    Article  PubMed  Google Scholar 

  14. Naveed M, Dunbar KB. Endoscopic imaging of Barrett’s esophagus. World J Gastrointest Endosc. 2016;8:259–66.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Sami SS, Subramanian V, Butt WM, Coleman BG, et al. High definition versus standard definition white light endoscopy for detecting dysplasia in patients with Barrett’s esophagus. Dis Esophagus. 2015;28:742–9.

    Article  CAS  PubMed  Google Scholar 

  16. Qumseya B, Wang H, Badie N, et al. Advanced imaging technologies increase detection of dysplasia and Neoplastia in patients with Barrett’s esophagus: a meta-analysis and systematic review. Clin Gastroenterol Hepatol. 2013;11:1562–70.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Tholoor S, Bhattacharyya R, Tsagkournis O, et al. Acetic acid Chromoendoscopy in Barrett’s esophagus surveillance is superior to the standardized random biopsy protocol: results from a large cohort study. Gastrointest Endosc. 2014;80(3):417–24.

    Article  PubMed  Google Scholar 

  18. Mannath J, Subramanian V, Hawkey CJ, et al. Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett’s esophagus: a meta-analysis. Endoscopy. 2010;42:351–9.

    Article  CAS  PubMed  Google Scholar 

  19. Sharma P, Bergman J, Goda K, et al. Development and validation of a classification system to identify high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus using narrow-band imaging. Gastroenterology. 2016;150:591–8.

    Article  PubMed  Google Scholar 

  20. Sharma P, Meining A, Coron E, et al. Real-time increased detection of neoplastic tissue in Barrett’s esophagus with probe-based Confocal laser Endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc. 2011;74(3):465–72.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Dunbar KB, Okolo P, Montgomery E, et al. Confocal laser endomicroscopy in Barrett’s esophagus and endoscopically inapparent Barrett’s neoplasia: a prospective, randomized, double-blind, controlled, crossover trial. Gastrointest Endosc. 2009;70:645–54.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Peters FP, Kara MA, Curvers WL, et al. Multiband mucosectomy for endoscopic resection of Barrett’s esophagus: feasibility study with matched historical controls. Eur J Gastroenterol Hepatol. 2007;19:311–5.

    Article  PubMed  Google Scholar 

  23. Hwang JH, Konda V, Dayyeh BKA, et al. Endoscopic mucosal resection. Gastrointest Endosc. 2015;82(2):215–26.

    Article  PubMed  Google Scholar 

  24. Konda V, Gonzalez HR, Koons A, et al. Complete endoscopic mucosal resection is effective and durable treatment for Barrett’s-associated Neoplasia. Clin Gastroenterol Hepatol. 2014;12(12):2002–10.

    Article  PubMed  Google Scholar 

  25. Tomizawa Y, Iyer PG, Song LMWK, et al. Safety of endoscopic mucosal resection for Barrett’s esophagus. Am J Gastroenterol. 2013;108:1440–7.

    Article  PubMed  Google Scholar 

  26. Barret M, Belghazi K, Weusten B, et al. Single-session endoscopic resection and focal radiofrequency ablation for short-segment Barrett’s esophagus with early Neoplasia. Gastrointest Endosc. 2016;84(1):29–36.

    Article  PubMed  Google Scholar 

  27. Seewald S, Ang TL, Gotoda T, et al. Total endoscopic resection of Barrett esophagus. Endoscopy. 2008;40:1016–20.

    Article  CAS  PubMed  Google Scholar 

  28. Terheggen G, Horn EM, Vieth M, et al. A randomised trial of endoscopic Submucosal dissection versus endoscopic mucosal resection for early Barrett’s Neoplasia. Gut. 2017;66(5):783–93.

    Article  PubMed  Google Scholar 

  29. Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med. 2009;360:2277–88.

    Article  CAS  PubMed  Google Scholar 

  30. Li N, Pasricha S, Bulsiewicz WJ, et al. Effects of preceding endoscopic mucosal resection on the efficacy and safety of radiofrequency ablation for treatment of Barrett’s esophagus: results from the United States radiofrequency ablation registry. Dis Esophagus. 2016;29(6):537–43.

    Article  CAS  PubMed  Google Scholar 

  31. Haidry R, Dunn J, Butt M, et al. Radiofrequency ablation and endoscopic mucosal resection for dysplastic Barrett’s esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA registry. Gastroenterology. 2013;145:87–95.

    Article  PubMed  Google Scholar 

  32. Kim HP, Bulsiewicz WJ, Cotton CC, et al. Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett’s esophagus with advanced neoplasia. Gastrointest Endosc. 2012;76:733–9.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Qumseya B, Wani S, Desai M, et al. Adverse events after radiofrequency ablation in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;16:1542–3565.

    Google Scholar 

  34. Gupta M, Iyer PG, Gorospe EC, et al. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett’s esophagus: results from a US multicenter consortium. Gastroenterology. 2013;145(1):79–86.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Augusta University Medical Center, Augusta, GA, USA

    Lavanya Viswanathan M.D., M.S., F.A.C.P.

  2. Veterans Affairs Medical Center and University of Kansas School of Medicine, Kansas City, KS, USA

    Prateek Sharma M.D.

Authors
  1. Lavanya Viswanathan M.D., M.S., F.A.C.P.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prateek Sharma M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lavanya Viswanathan M.D., M.S., F.A.C.P. .

Editor information

Editors and Affiliations

  1. Institute of Gastroenterology, Sheba medical Center, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel

    Eytan Bardan

  2. Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    Reza Shaker

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Viswanathan, L., Sharma, P. (2018). Barrett’s Esophagus: Am I Going to Get Cancer? What Should I Do to Avoid It?. In: Bardan, E., Shaker, R. (eds) Gastrointestinal Motility Disorders . Springer, Cham. https://doi.org/10.1007/978-3-319-59352-4_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59352-4_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59350-0

  • Online ISBN: 978-3-319-59352-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation